
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
There is increasing evidence that environmental toxicants affect kids' health. Given this reality, pediatricians need to know the most important environmental health questions to ask, and what resources to draw from.






